These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20842468)

  • 1. Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.
    Obrzut S; Tiongson J; Jamshidi N; Phan HM; Hoh C; Birgersdotter-Green U
    J Cardiovasc Transl Res; 2010 Dec; 3(6):643-51. PubMed ID: 20842468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between myocardial substrate utilization, oxygen consumption and regional oxygen balance in the dog heart in vivo.
    Furman E; Sonn J; Acad BA; Dvir S; Kedem J
    Arch Int Physiol Biochim; 1986 Dec; 94(5):285-93. PubMed ID: 2440404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy.
    Neglia D; De Caterina A; Marraccini P; Natali A; Ciardetti M; Vecoli C; Gastaldelli A; Ciociaro D; Pellegrini P; Testa R; Menichetti L; L'Abbate A; Stanley WC; Recchia FA
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3270-8. PubMed ID: 17921325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On substrate selection for ATP synthesis in the failing human myocardium.
    Ingwall JS
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3225-6. PubMed ID: 17921320
    [No Abstract]   [Full Text] [Related]  

  • 6. Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.
    Zavadovsky KV; Gulya MO; Lishmanov YB; Lebedev DI
    Ann Nucl Med; 2016 Jun; 30(5):325-33. PubMed ID: 26872805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
    Voros G; Ector J; Garweg C; Droogne W; Van Cleemput J; Peersman N; Vermeersch P; Janssens S
    Circ Heart Fail; 2018 Dec; 11(12):e004953. PubMed ID: 30562098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.
    Mitro P; Murin P; Valocik G; Simurda M
    Cardiol J; 2014; 21(5):524-31. PubMed ID: 24526506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Glucose Tolerance Is Associated with a Reduced Myocardial Metabolic Flexibility in Patients with Dilated Cardiomyopathy.
    Tricò D; Baldi S; Frascerra S; Venturi E; Marraccini P; Neglia D; Natali A
    J Diabetes Res; 2016; 2016():3906425. PubMed ID: 26798650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.
    Qiu Q; Chen YX; Mai JT; Yuan WL; Wei YL; Liu YM; Yang L; Wang JF
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):329-37. PubMed ID: 25392055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retained Metabolic Flexibility of the Failing Human Heart.
    Watson WD; Green PG; Lewis AJM; Arvidsson P; De Maria GL; Arheden H; Heiberg E; Clarke WT; Rodgers CT; Valkovič L; Neubauer S; Herring N; Rider OJ
    Circulation; 2023 Jul; 148(2):109-123. PubMed ID: 37199155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.
    Da Costa A; Thévenin J; Roche F; Faure E; Roméyer-Bouchard C; Messier M; Convert G; Barthélemy JC; Isaaz K
    Heart Rhythm; 2006 Apr; 3(4):406-13. PubMed ID: 16567286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of coronary flow reserve for left ventricular functional improvement after cardiac resynchronization therapy in patients with dilated cardiomyopathy.
    Djordjevic Dikic A; Nikcevic G; Raspopovic S; Jovanovic V; Tesic M; Beleslin B; Stepanovic J; Giga V; Milasinovic G
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1344-9. PubMed ID: 25053732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with non-ischaemic dilated cardiomyopathy using equilibrium radionuclide angiography.
    Mukherjee A; Patel CD; Naik N; Sharma G; Roy A
    Europace; 2016 Jun; 18(6):851-7. PubMed ID: 26056184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution.
    Castellant P; Fatemi M; Orhan E; Etienne Y; Blanc JJ
    Europace; 2009 Mar; 11(3):350-5. PubMed ID: 19240110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fatty acid metabolism and cardiac performance in heart failure.
    Tuunanen H; Ukkonen H; Knuuti J
    Curr Cardiol Rep; 2008 Mar; 10(2):142-8. PubMed ID: 18417015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure.
    Wallhaus TR; Taylor M; DeGrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    Circulation; 2001 May; 103(20):2441-6. PubMed ID: 11369683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of cardiac resynchronization therapy in patients with isolated ventricular noncompaction with dilated cardiomyopathy: a systematic review of the literature.
    Bertini M; Balla C; Pavasini R; Boriani G
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):324-328. PubMed ID: 29877973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.